NCT00646230 2023-04-07
IV Fenretinide
Children's Hospital Los Angeles
Phase 1 Completed
Clinical Trials
5 trialsNCT02163356 2022-03-31
SPOC2013-001
South Plains Oncology Consortium
Phase 1 Terminated
NCT00006080 2018-06-27
Fenretinide in Treating Patients With Recurrent Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00053326 2013-10-08
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003191 2013-02-07
Fenretinide in Treating Children With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed